Cargando…
Correction: Intravenous Therapy Duration and Outcomes in Melioidosis: A New Treatment Paradigm
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406616/ https://www.ncbi.nlm.nih.gov/pubmed/25901744 http://dx.doi.org/10.1371/journal.pntd.0003737 |
Ejemplares similares
-
Intravenous Therapy Duration and Outcomes in Melioidosis: A New Treatment Paradigm
por: Pitman, Matthew C., et al.
Publicado: (2015) -
Correction: Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis
por: Birnie, Emma, et al.
Publicado: (2020) -
Correction to: Treatment duration with immune-based therapies in Cancer: an enigma
por: Bantia, Shanta, et al.
Publicado: (2019) -
Correction to: New paradigm for stage III melanoma: from surgery to adjuvant treatment
por: Ascierto, Paolo Antonio, et al.
Publicado: (2019) -
Correction: Evaluation of antigen-detecting and antibody-detecting diagnostic test combinations for diagnosing melioidosis
Publicado: (2022)